Log In
Print
BCIQ
Print
Print this Print this
 

Anti-CD38

  Manage Alerts
Collapse Summary General Information
Company ProMIS Neurosciences Inc.
Description mAb against CD38 disease specific epitopes (DSEs)
Molecular Target CD38
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationLeukemia
Indication DetailsTreat leukemia
Regulatory Designation
Partner Apexigen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today